Nadav Kidron

2012

In 2012, Nadav Kidron earned a total compensation of $266.1K as President and CEO at Oramed Pharmaceuticals.

Compensation breakdown

Option Awards$88,927
Salary$159,136
Other$17,989
Total$266,052

Kidron received $159.1K in salary, accounting for 60% of the total pay in 2012.

Kidron also received $88.9K in option awards and $18K in other compensation.

Rankings

In 2012, Nadav Kidron's compensation ranked 10,393rd out of 11,487 executives tracked by ExecPay. In other words, Kidron earned more than 9.5% of executives.

ClassificationRankingPercentile
All
10,393
out of 11,487
10th
Division
Manufacturing
3,863
out of 4,253
9th
Major group
Chemicals And Allied Products
1,087
out of 1,203
10th
Industry group
Drugs
832
out of 925
10th
Industry
Pharmaceutical Preparations
630
out of 700
10th
Source: SEC filing on June 17, 2014.

Kidron's colleagues

We found two more compensation records of executives who worked with Nadav Kidron at Oramed Pharmaceuticals in 2012.

2012

Miriam Kidron

Oramed Pharmaceuticals

Chief Medical and Technology Officer

2012

Yifat Zommer

Oramed Pharmaceuticals

Chief Financial Officer

News

You may also like